See if You Qualify for
Stem Cell Therapy

Request
FREE CONSULTATION


    See our privacy policy

     
   

Organizations that
Charles H. Newcomer
Dr. Ernesto Gutierrez
Are members of

icms
Awareness for Charcot Marie Tooth Neuromuscular Disease
Awareness for Charcot Marie Tooth Neuromuscular Disease
Stem Cell Clinical Trials
Stem Cell Clinical Trials
Stem Cell Research
Stem Cell Research
Tissue Regeneration
Tissue Regeneration
Regenerative Medicine Technology
Regenerative Medicine Technology
Diabetes Research Institute Foundation
Diabetes Research Institute Foundation
Society for Laboratory Automation and Screening
Society for Laboratory Automation and Screening (SLAS)
Stem Cells & Regenerative Medicines Network
Stem Cells & Regenerative Medicines Network
Israel stem cell regen industry
Israel stem cell regen industry
Advances in Stem Cell Discoveries Society
Advances in Stem Cell Discoveries Society


Autologous Stem Cells

Autologous stem cells (adult) are derived from the patient’s own blood, bone marrow or adipose (fat). Autologous adult stem cells have the ability to manufacture all blood cells (red and white) and provide the needed stem cells to repair tissues and organs of the body. They are found in bone marrow that continually replenishes older blood, with new cells.

An Autologous (adult) stem cell transplant is the infusion of stem cells, from your own bodies’ stores that are concentrated and replace into your body. A stem cell transplant can help your body make enough healthy white blood cells, red blood cells or platelets, and reduce your risk of life-threatening infections, anemia, bleeding, aids in

Autologous Stem Cells are broken down into specific cell line types based on categories of adult, autologous cells. ICMS defines cell lines by their common embryonic origin, state of differentiation, and cell types that can be produced by differentiation.

Mesechymal Stem Cells (MSCs): A multipotent stem cell (GLSC) that is self-renewing and adherent, which make up a very small fraction of the marrow stroma. These non-hematopoietic stromal cells are usually harvested from a patient’s bone marrow or other tissues of mesodermal origin (fat, joint synovium, dental pulp, etc…).[1-13] They can be isolated based on adherence and can be culture expanded in vitro. These cells may differentiate into various inflammatory issues and provides stem cells for the repair of damaged tissues and organs. mesenchyme-derived cell types. They generally do not circulate in the peripheral blood, but rather are resident in the mesenchymal tissues they serve.

Hematopoietic Stem Cells (HSC’s): A multipotent stem cell (GLSC) that is self-renewing and non-adherent. This stem cell gives rise to all blood types (including myeloid and lymphoid lineages) and is usually derived from either the patient’s bone marrow or mobilized peripheral blood.[14] They can be isolated with centrifugation or antibody selection and can be culture expanded in vitro (usually only in the presence of other marrow stromal cells, in particular MSCs). These cells can circulate in the peripheral blood.

Neural Stem Cell (NSC): A multipotent stem cell (GLSC) found in adult neural tissue that can give rise to neurons and glial (supporting) cells.[15] These cells do not circulate in the peripheral blood, but serve their resident tissues.
Endothelial Progenitor Cell (EPC): A multipotent stem cell (GLSC) found in bone marrow that participates in vasculogenesis.[16] These cells do circulate in the peripheral blood in response to vascular injury.

Epithelial Stem Cell (ESC): A multipotent stem cell (GLSC) that resides in the dermis and is controlled by epithelial-mesenchymal interactions.[17-20] This cell gives rise to new dermal tissue and other tissues of epithelial origin. These cells are resident in the tissues they serve.

Very Small Embryonic Like Cell (VSEL): A totipotent stem cell (TSC) that resides in the bone marrow and also circulates in the peripheral blood during times of tissue injury.[21-23]
More specific descriptors (phenotype and genotype) of different cell populations produced by a specific cell culture process are possible, but often problematic. As an example, cell surface markers are variable even with the same stem cell line. For example, mesenchymal stem cells have variable markers with very few markers being generally agreed upon as likely MSC specific.[24-29] HSC’s are better defined by cell surface markers (usually CD34+), but CD34- HSC’s have been identified.[30] VSEL’s can be identified by cell surface markers (usually CXCR4+ Sca-1+ Lin− CD45−, expressing SSEA – 1/4, Oct – 4 and Nanog). EPC’s and ESC’s are less well defined by markers. In addition, new stem cell surface markers to assay are still being discovered. Even genetic profiling is difficult as a definitive identification tool, as different levels of gene expression are also seen within the same stem cell line.[31]. In addition, many adult cells have paracrine functions that would be difficult to assay.[32-37]

For More Info:
http://www.cellmedicinesociety.org/attachments/370_Section%207%20-%20Clinical%20Guidelines%20for%20the%20Practice%20of%20Cell%20Based%20Medicine.pdf

Share:Share on Facebook0Pin on Pinterest0Tweet about this on Twitter0Share on Google+0Share on LinkedIn0

Testimonials

  • Stem Cell Treatment or Hip Surgery

    Stem Cell Treatment or Hip Surgery

    I have grade IV osteoarthritis (severe loss of cartilage leading to bone rubbing on bone) of my right hip. I have seen 3 orthopedic doctors, all of which have said I need to have surgery for hip replacement. Additional options for treatment were limited. As a nurse, and at my age, having seen both good and bad outcomes following hip replacement, and also knowing hip replacement is not without risk, I chose to seek other options of treatment for myself.

    Read more
  • AUTISM a stem cell treatment success

    AUTISM a stem cell treatment success

    Andrew is thriving. We have seen and continue to see major improvements. He has matured beyond anything I can explain (I have had to rapidly adjust my parenting as I now have a much older & more sophisticated child), his comprehension (perhaps better to say his ability to express and act upon his comprehension) is now age appropriate.

    Read more
  • Hello

    owen_pic

    Hello, When we came from Cancun the first week we noticed an improvement in eye contact. It improved about 70%. His attention improved about 50% and he was more in our world when it comes to understand what it happening around him. He lost some of his attention for the last two weeks but it is still better than it was prior stem cells and even Janik BIs therapist say it is easier to work with Janik in ABA because his eye contact is better and his focus is also better."

    Read more
  • Owen, happy again

    Owen-pic-2

    Well Owen is happy again, which is the biggest improvement. He is laughing and giggling again. His eye contact has improved and he is playing with toys again. All of these things had stopped. I`m so happy that he is happy. ( His Mom)Read more

News

  • Another COPD Stem cell treatment success:

    March 17th, 2014

    World Stem Cells, LLC http://worldstemcells.com/ patients are reporting successes and are providing testimoni

     

    Read more

  • COPD Stem cell treatment success:

    February 4th, 2014

    TAMPA, FLORIDA 2-3-14 World Stem Cells, LLC http://worldstemcells.com/ patients are reporting successes and

     

    Read more

  • Stem Cell Treatments 2014 “Times are changing”:

    January 7th, 2014

    Stem Cell Treatments "Times are changing" -- Ten, twenty years ago the words "Stem Cells" were seen as a fairy tale or the working

     

    Read more

Be sure to visit our Blog!

    • There is a wealth of information available on Stem Cell therapy and the emerging field in general. Many of our patients have asked me to present further information and give them a working knowledge of the terms and general information necessary to understand the industry. Under the Stem Cell Glossery section of our website are some of the most used terms. A posting of additional resources will be present shortly.

      Please note that we will be posting a number of clips for this purpose. In our YouTube area check for the updates. A recent lecture series given at the Annual Gathering of Mensa 2011 will be included.

      Recently a number of clinics have begun selling "cells" for treatments. The treatments are via IV and all sorts of claims are being made. The idea of the franchise of stem cell centers is the opposite of personalized medicine and clearly not the direction that I feel will benefit the majority of patients.

      As a consumer the buyer beware "caveat emptor " needs to be heightened in the competitive environment of questionable practices by "cell" salesman/women.
*DISCLAIMER: As with any medical treatment, no guarantees or claim of cures are made as to the extent of the response to treatment. Results vary from patient to patient, even with a similar diagnosis, as the body's internal status is unique to each individual patient. Because of this fact we cannot offer, infer or suggest that there is any certainty of a given outcome. Many of our treatments are not currently FDA approved. We do not use embryonic or fetal cells in any of our treatments.
Copy Protected by Chetans WP-Copyprotect.